This company seems to have been delisted
Reason: Filed for bankruptcy
Last recorded trade on: June 22, 2023
Source: https://www.bloomberg.com/news/articles/2023-05-03/generic-drugmaker-lannett-files-for-chapter-11-bankruptcy
Reason: Filed for bankruptcy
Last recorded trade on: June 22, 2023
Source: https://www.bloomberg.com/news/articles/2023-05-03/generic-drugmaker-lannett-files-for-chapter-11-bankruptcy
Lannett Company
LCI
A$1.05
Share price
0.00%
Change (1 day)
-68.79%
Change (1 year)
Categories
Lannett Company (LCI) - Total debt
Total debt on the balance sheet as of March 2023 : A$0.98 Billion
According to Lannett Company's latest financial reports the company's total debt is A$0.98 Billion. A company’s total debt is the sum of all current and non-current debts.
Lannett Company - Total debt on balance sheet (from 1999 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-06-30 | A$0.90 B | 12.88% |
| 2021-06-30 | A$0.80 B | -19.69% |
| 2020-06-30 | A$1.00 B | -3.4% |
| 2019-06-30 | A$1.03 B | -8.44% |
| 2018-06-30 | A$1.13 B | -3.68% |
| 2017-06-30 | A$1.17 B | -17.44% |
| 2016-06-30 | A$1.42 B | 108603.2% |
| 2015-06-30 | A$1.31 M | 8.66% |
| 2014-06-30 | A$1.2 M | -83.09% |
| 2013-06-30 | A$7.13 M | 2.06% |
| 2012-06-30 | A$6.99 M | -4.2% |
| 2011-06-30 | A$7.29 M | -19.93% |
| 2010-06-30 | A$9.11 M | -9.41% |
| 2009-06-30 | A$10.06 M | 7.16% |
| 2008-06-30 | A$9.38 M | -17.88% |
| 2007-06-30 | A$11.43 M | 3.16% |
| 2006-06-30 | A$11.08 M | -11.3% |
| 2005-06-30 | A$12.49 M | -14.51% |
| 2004-06-30 | A$14.61 M | 215.05% |
| 2003-06-30 | A$4.63 M | -37.14% |
| 2002-06-30 | A$7.37 M | -64.94% |
| 2001-06-30 | A$21.05 M | 99.04% |
| 2000-06-30 | A$10.57 M | -24.81% |
| 1999-06-30 | A$14.06 M | -20.41% |
| 1998-06-30 | A$17.67 M | 48.22% |
| 1997-06-30 | A$11.92 M | 30.14% |
| 1996-06-30 | A$9.16 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | A$94.06 B | 9,482.29% | 🇺🇸 USA |
 Johnson & Johnson JNJ | A$80.19 B | 8,069.12% | 🇺🇸 USA |
 Abbott Laboratories ABT | A$20.32 B | 1,970.27% | 🇺🇸 USA |
 Novartis NVS | A$47.98 B | 4,788.78% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | A$36.54 B | 3,623.38% | 🇬🇧 UK |